1-(2-{2-[(Propan-2-yl)oxy]ethoxy}ethoxy)butane | 25961-88-0

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1-(2-{2-[(Propan-2-yl)oxy]ethoxy}ethoxy)butane
• 英文别名: 1-[2-(2-propan-2-yloxyethoxy)ethoxy]butane
• CAS: 25961-88-0
• 化学式: C₁₁H₂₄O₃
• 分子量: 204.31
• InChiKey: SVSKFSUPPCVHMA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  14
• 可旋转键数：
  10
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  27.7
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• BLOCKED POLYISOCYANATE COMPOSITION AND USE THEREOF
  申请人：Asahi Kasei Kabushiki Kaisha

  公开号：EP3689936A1

  公开（公告）日：2020-08-05

  A blocked polyisocyanate composition containing a blocked polyisocyanate obtained from a polyisocyanate and at least one blocking agent, wherein the blocking agent contains a compound represented by general formula (I) shown below, and the amount of methane tetracarbonyl structures represented by general formula (II) shown below, relative to the total molar amount within the blocked polyisocyanate of bonded structures in which the compound represented by general formula (I) is bonded to the polyisocyanate, is at least 0.5 mol% but not more than 10 mol%.

  一种封端多异氰酸酯组合物，含有由多异氰酸酯和至少一种封端剂得到的封端多异氰酸酯，其中封端剂含有下图所示通式(I)代表的化合物，且下图所示通式(II)代表的甲烷四羰基结构的量，相对于封端多异氰酸酯中通式(I)代表的化合物与多异氰酸酯键合的键合结构的总摩尔量，至少为 0.5 摩尔%，但不超过 10 摩尔%。
• EP0886719A1
  申请人：——

  公开号：EP0886719A1

  公开（公告）日：1998-12-30
• Photosensitive resin composition, thin film panel made with photosensitive resin composition, and method for manufacturing thin film panel
  申请人：Lee Hi-Kuk

  公开号：US20070254221A1

  公开（公告）日：2007-11-01

  A photosensitive resin composition includes an alkali-soluble resin, a quinone diazide, a surfactant, and a solvent. The surfactant includes an organic fluorine compound having the structure a first silicone compound having the structure a second silicone compound having the structure The resin composition may be used in display panels.
• [EN] A PROCESS AND A FORMULATION TO INHIBIT SCALE IN OIL FIELD PRODUCTION<br/>[FR] PROCEDE ET FORMULATION SERVANT A EMPECHER LES DEPOTS CALCAIRES DANS UNE EXPLOITATION PETROLIERE
  申请人：BP CHEMICALS LIMITED

  公开号：WO1998030783A1

  公开（公告）日：1998-07-16

  (EN) This invention is a process and a formulation for minimising the squeezing and shut-in operations needed to inhibit scale in a production well using the precipitation squeeze method by injecting into an oil-bearing rock formation a water-miscible formulation comprising: (a) a water-miscible surfactant which is in liquid form, (b) a solution of water-soluble metal salt comprising a multivalent cation and (c) a solution of a water-miscible scale-inhibiting compound comprising an anionic component capable of forming a scale-inhibiting precipitate $i(in situ) in the presence of the cations in (b) upon injection into the rock formation, wherein the surfactant is a glycol ether and the minimum ion concentration of the scale-inhibiting compound (c) is 5000 ppm based on the total weight of the formulation.(FR) L'invention concerne un procédé et une formulation servant à limiter au minimum les opérations d'injection et de compression d'une composition aqueuse contenant un inhibiteur de calcaire dans un puits de production. Ce procédé de compression et de précipitation consiste à injecter dans une formation rocheuse pétrolifère une formulation miscible dans l'eau comprenant: (a) un tensioactif miscible dans l'eau sous forme liquide, (b) une solution d'un sel de métal soluble dans l'eau contenant un cation polyvalent et (c) une solution d'un composé miscible dans l'eau inhibant la formation de calcaire et contenant un constituant anionique capable de former un précipité inhibant le calcaire dans la formation rocheuse en présence des cations de (b) lorsqu'on l'injecte dans la formation, le tensioactif étant un glycol éther et la concentration minimum d'ions du composé (c) étant de 5000 ppm sur la base du poids total de la formulation.
• [EN] ANTI-CD74 ANTIBODY CONJUGATES, COMPOSITIONS COMPRISING ANTI-CD74 ANTIBODY CONJUGATES AND METHODS OF USING ANTI-CD74 ANTIBODY CONJUGATES<br/>[FR] CONJUGUÉS D'ANTICORPS ANTI-CD74, COMPOSITIONS COMPRENANT DES CONJUGUÉS D'ANTICORPS ANTI-CD74 ET MÉTHODES D'UTILISATIONS DESDITS CONJUGUÉS D'ANTICORPS ANTI-CD74
  申请人：SUTRO BIOPHARMA INC

  公开号：WO2017132615A1

  公开（公告）日：2017-08-03

  Provided herein are antibody conjugates with binding specificity for CD74, wherein the antibody comprises a non-natural amino acid at a site selected from the group consisting of HC-F404, HC-K121, HC-Y180, HC-F241, HC-221, LC-T22, LC-S7, LC-N152, LC-K42, LC-E161, LC-D170, HC-S136, HC-S25, HC-A40, HC-S119, HC-S190, HC-K222, HC-R19, HC-Y52, or HC-S70, according to the Kabat, Chothia, or EU numbering scheme, and compositions comprising the antibody conjugates, including pharmaceutical compositions, methods of producing the conjugates, and methods of using the conjugates and compositions for therapy.